Medicare Part D Defeat Shows Perils Of Agency Overreach

Law360, New York (March 11, 2014, 8:17 PM EDT) -- The Obama administration’s epic retreat from a major overhaul of Medicare Part D was a cautionary tale for regulators who float grand plans without first getting buy-in from corporations and beneficiaries, according to experts who say the changes nonetheless could return in retooled forms and shake up business for drugmakers, pharmacies and insurers.

In a proposed rule whose biggest components were in the end largely abandoned, the Centers for Medicare and Medicaid Services wanted to alter prescription drug pricing, coverage and insurance policies significantly in a program...
To view the full article, register now.